Dr. Marc Schepens, Chirurg
0821.638.005 · rovalta.com · 24/09/2026
NORMAL SITUATION
Dr. Marc Schepens, Chirurg
Company — Normal situation.
Financial year 2024 · Closed on 30/06/2024
Net result
217,5 k €
+18,3 %over 1 yearGross margin
259,7 k €
-9,2 %over 1 yearEquity
2 M €
+12,1 %over 1 yearOverview
Identity
Source · BCE/KBODr. Marc Schepens, Chirurg is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0821.638.005
- Legal form
- Private limited company
- Contributed capital
- 18 550,00 €
- Latest accounts
- 30/06/2024
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 14 filingsTrend over 14 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 259,7 k € | -9.2% | 286 k € | +18.1% | 242,1 k € | -38.4% | 393,2 k € | +68.4% | 233,5 k € |
| EBITDA | 252,3 k € | -8.7% | 276,3 k € | +15.1% | 239,9 k € | -38.7% | 391,5 k € | +69.2% | 231,3 k € |
| Operating result | 251,4 k € | -5.7% | 266,7 k € | +15.0% | 231,8 k € | -39.4% | 382,9 k € | +71.7% | 223 k € |
| Net result | 217,5 k € | +18.3% | 183,9 k € | +34.3% | 137 k € | -50.4% | 276 k € | +91.2% | 144,3 k € |
| Balance sheet | |||||||||
| Equity | 2 M € | +12.1% | 1,8 M € | +11.3% | 1,6 M € | +9.2% | 1,5 M € | +22.9% | 1,2 M € |
| Total assets | 2,1 M € | +10.8% | 1,9 M € | +11.0% | 1,7 M € | +6.2% | 1,6 M € | +24.6% | 1,3 M € |
| Cash | 1,8 M € | +18.5% | 1,5 M € | +12.4% | 1,4 M € | +1.7% | 1,3 M € | +30.2% | 1 M € |
| Debts | 54,7 k € | -21.1% | 69,4 k € | +4.0% | 66,8 k € | -35.8% | 104 k € | +55.1% | 67 k € |
Board of directors
Source · NBB, accounts to 30/06/20241 active · 2 ended
Active mandates
Marc Schepens
ActiveEnded mandates
Schepens Marc
EndedMarc Schepens
EndedFinancials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/07/2023 | 01/07/2022 | 01/07/2021 | 01/07/2020 | 01/07/2019 | 01/07/2018 |
| Closing of the financial year | 30/06/2024 | 30/06/2023 | 30/06/2022 | 30/06/2021 | 30/06/2020 | 30/06/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 24/09/2024 | 22/12/2023 | 26/01/2023 | 28/12/2021 | 25/01/2021 | 06/11/2019 |
| General meeting | 21/09/2024 | 21/12/2023 | 23/01/2023 | 27/12/2021 | 28/12/2020 | 15/10/2019 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 14 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 30/06/2024 | 21/09/2024 | 24/09/2024 | Dutch | |
| Micro model | 30/06/2023 | 21/12/2023 | 22/12/2023 | Dutch | |
| Micro model | 30/06/2022 | 23/01/2023 | 26/01/2023 | Dutch | |
| Micro model | 30/06/2021 | 27/12/2021 | 28/12/2021 | Dutch | |
| Micro model | 30/06/2020 | 28/12/2020 | 25/01/2021 | Dutch | |
| Micro model | 30/06/2019 | 15/10/2019 | 06/11/2019 | Dutch | |
| Abridged model | 30/06/2018 | 31/12/2018 | 30/01/2019 | Dutch | |
| Abridged model | 30/06/2017 | 25/12/2017 | 01/02/2018 | Dutch | |
| Abridged model | 30/06/2016 | 26/12/2016 | 24/01/2017 | Dutch | |
| Abridged model | 30/06/2015 | 28/12/2015 | 19/01/2016 | Dutch | |
| Abridged model | 30/06/2014 | 29/12/2014 | 05/01/2015 | Dutch | |
| Abridged model | 30/06/2013 | 30/12/2013 | 06/01/2014 | Dutch | |
| Abridged model | 30/06/2012 | 28/12/2012 | 02/01/2013 | Dutch | |
| Abridged model | 30/06/2011 | 09/11/2011 | 12/12/2011 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/06/20241 active · 2 ended
Active mandates
Marc Schepens
ActiveEnded mandates
Schepens Marc
EndedMarc Schepens
EndedOwnership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 2024217,5 k €↑
- 2023Annual accounts 2023183,9 k €↑
- 2022Annual accounts 2022137 k €↓
- 2021Annual accounts 2021276 k €↑
- 2020Annual accounts 2020144,3 k €↑
- 2019Annual accounts 2019127,9 k €↓
- 2018Annual accounts 2018175,2 k €↑
- 2017Annual accounts 2017149,9 k €↑
- 2016Annual accounts 2016129,5 k €↓
- 2015Annual accounts 2015158,1 k €↓
- 2014Annual accounts 2014188,3 k €↓
- 2013Annual accounts 2013192,6 k €↓
- 2012Annual accounts 2012201,9 k €↓
- 2011Annual accounts 2011390,5 k €